stockrow
Friday 6 November 2026
Export DXR’s income statement to Excel — free account
Daxor Corporation
DXR Healthcare Medical Instruments & Supplies
Daxor Corporation’s revenue for fiscal 2022 (year ended December 2022) was −$353,400.00.
8.63
0.28
−3.14%
Follow DXR
Alert me
Daxor Corporation (DXR) P/E ratio
As of 5 November 2026, Daxor Corporation (DXR) trades at a P/E ratio of 4.0×. Over the past ten years it has ranged from 0.0× (December 2021) to 18.3× (June 2022); the current reading is higher than 69% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2022 | 3.7× | (76.57%) |
| FY2021 | 15.7× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
| FY2015 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2023 | 4.5× | 21.55% |
| Dec 2022 | 3.7× | (66.88%) |
| Jun 2022 | 11.1× | (29.26%) |
| Dec 2021 | 15.7× | — |
| 7 more quarters | Free account |
Against its own ten years
Low 0.0×
High 18.3×
Ten-year median
0.0×
Current reading's percentile
24
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| STXS Stereotaxis Inc. compare | n/m |
| KRMD KORU Medical Systems, Inc. compare | n/m |
| POCI Precision Optics Corp. compare | n/m |
| MLSS Milestone Scientific, Inc. compare | n/m |
| HBIO Harvard Bioscience, Inc. compare | n/m |
| ZTEKF Zentek Ltd. compare | n/m |
| DXR Daxor Corporation | 4.0× |
| NEPH Nephros Inc. compare | 18.0× |
| DAVI Davion Healthcare PLC compare | — |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)